Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels

Brain, Behavior, and Immunity

Volumn 37, Issue , 2014, Pages 152-163

  Pedreño, Marta ^a   Morell, Maria ^a   Robledo, Gema ^a   Souza Moreira, Luciana ^a   Forte Lago, Irene ^a   Caro, Marta ^a   O'Valle, Francisco ^b   Ganea, Doina ^c   Gonzalez Rey, Elena ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenomedullin; Autoimmunity; Dendritic cells; Glial cells; Multiple sclerosis; Neuropeptide; Regulatory T cells

Indexed keywords

ADRENOMEDULLIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; OSTEOPONTIN; PERTUSSIS TOXIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; AXONAL INJURY; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; DENDRITIC CELL; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FLACCID PARALYSIS; FLOW CYTOMETRY; GAIT DISORDER; GLIA CELL; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PARESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPINAL CORD; SPLEEN CELL; SYSTEMIC THERAPY; TH1 CELL; TH17 CELL;

ADRENOMEDULLIN; AUTOIMMUNITY; DENDRITIC CELLS; GLIAL CELLS; MULTIPLE SCLEROSIS; NEUROPEPTIDE; REGULATORY T CELLS;

ADRENOMEDULLIN; ANIMALS; BRAIN; CHRONIC DISEASE; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; LYMPH NODES; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; SPINAL CORD; SPLEEN;

EID: 84896698729     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.11.021     Document Type: Article

References (63)

1. Baxter A.G. The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 2007, 7:904-912.
2. Braitch M., Kawabe K., Nyirenda M., Gilles L.J., Robins R.A., Gran B., Murphy S., Showe L., Constantinescu C.S. Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis. Neuroimmunomodulation 2010, 17:120-125.
3. Bynoe M.S., Evans J.T., Viret C., Janeway C.A. Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis. Immunity 2003, 19:317-328.
4. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., Heller R. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001, 294:1731-1735.
5. Cheung B.M., Ong K.L., Tso A.W., Leung R.Y., Cherny S.S., Sham P.C., Lam T.H., Lam K.S. Plasma adrenomedullin level is related to a single nucleotide polymorphism in the adrenomedullin gene. Eur. J. Endocrinol. 2011, 165:571-577.
6. Chorny A., Gonzalez-Rey E., Fernandez-Martin A., Pozo D., Ganea D., Delgado M. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proc. Natl. Acad. Sci. USA 2005, 102:13562-13567.
7. Chosa E., Hamada H., Kitamura K., Eto T., Tajima N. Increased plasma and joint tissue adrenomedullin concentrations in patients with rheumatoid arthritis compared to those with osteoarthritis. J. Rheumatol. 2003, 30:2553-2556.
8. Chu C.Q., Wittmer S., Dalton D.K. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 2000, 192:123-128.
9. Codarri L., Gyülvészi G., Tosevski V., Hesske L., Fontana A., Magnenat L., Suter T., Becher B. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011, 12:560-567.
10. Consonni A., Morara S., Codazzi F., Grohovaz F., Zacchetti D. Inhibition of lipopolysaccharide-induced microglia activation by calcitonin gene related peptide and adrenomedullin. Mol. Cell. Neurosci. 2011, 48:151-160.
11. Cui X., Wu R., Zhou M., Dong W., Ulloa L., Yang H., Wang H., Tracey K.J., Simms H.H., Wang P. Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage. Crit. Care Med. 2005, 33:391-398.
12. Elsasser T.H., Kahl S. Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response. Microsc. Res. Tech. 2002, 57:120-129.
13. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C.G. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996, 156:5-7.
14. Gibbons C., Dackor R., Dunworth W., Fritz-Six K., Caron K.M. Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling. Mol. Endocrinol. 2007, 21:783-796.
15. Gonzalez-Rey E., Chorny A., Robledo G., Delgado M. Urocortin and adrenomedullin prevent lethal endotoxemia by downregulating the inflammatory response. Am. J. Pathol. 2006, 168:1921-1930.
16. Gonzalez-Rey E., Fernandez-Martin A., Chorny A., Delgado M. Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease. Gut 2006, 55:824-832.
17. Gonzalez-Rey E., Chorny A., O'Valle F., Delgado M. Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells. Am. J. Pathol. 2007, 170:263-271.
18. Gonzalez-Rey E., Chorny A., Delgado M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat. Rev. Immunol. 2007, 7:52-63.
19. Goverman J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9:393-407.
20. Hinson J.P., Kapas S., Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 2000, 21(2):138-167.
21. Hu X., Ivashkiv L.B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-550.
22. Ishimitsu T., Miyata A., Matsuoka H., Kangawa K. Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells. Biochem. Biophys. Res. Commun. 1998, 243:463-470.
23. Jager A., Dardalhon V., Sobel R.A., Bettelli E., Kuchroo V.K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 2009, 183:7169-7177.
24. Jansson M., Panoutsakopoulou V., Baker J., Klein L., Cantor H. Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontindeficient mice. J. Immunol. 2002, 168:2096-2099.
25. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Comm. 1993, 192:553-560.
26. Klein M., Vaeth M., Scheel T., Grabbe S., Baumgrass R., Berberich-Siebelt F., Bopp T., Schmitt E., Becker C. Repression of cyclic adenosine monophosphate upregulation disarms and expands human regulatory T cells. J. Immunol. 2012, 188(3):1091-1097.
27. Kluver H., Barrera E. A method for the combined staining of cells and fibers in the nervous system. J. Neuropathol. Exp. Neurol. 1953, 12:400-403.
28. Kohm A.P., Carpentier P.A., Anger H.A., Miller S.D. CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 2002, 169:4712-4716.
29. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
30. Kong W., Yen J.H., Ganea D. Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis. Brain Behav. Immun. 2011, 25:872-882.
31. Koo D.J., Zhou M., Chaudry I.H., Wang P. The role of adrenomedullin in producing differential hemodynamic responses during sepsis. J. Surg. Res. 2001, 95:207-218.
32. Kubo A., Minamino N., Isumi Y., Kangawa K., Dohi K., Matsuo H. Adrenomedullin production is correlated with differentiation in human leukemia cell lines and peripheral blood monocytes. FEBS Lett. 1998, 426:233-237.
33. Kubo A., Minamino N., Isumi Y., Katafuchi T., Kangawa K., Dohi K., Matsuo H. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J. Biol. Chem. 1998, 273:16730-16738.
34. Lewin G.R., Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 1996, 19:289-317.
35. Linker R.A., Lee D.H., Demir S., Wiese S., Kruse N., Siglienti I., Gerhardt E., Neumann H., Sendtner M., Lühder F., Gold R. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 2010, 133:2248-2263.
36. Mak A., Cheung B.M.Y., Mok C.C., Leung R., Lau C.S. Adrenomedullin- a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus. Rheumatology 2006, 45:1266-1272.
37. Maldonado R.A., von Andrian U.H. How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 2010, 108:111-165.
38. Martinez-Herrero S., Martinez A. Cancer protection elicited by a single nucleotide polymorphism close to the adrenomedullin gene. J. Clin. Endocrinol. Metab. 2013, 98:E807-E810.
39. Miller S.D., Karpus W.J., Davidson T.S. Experimental autoimmune encephalomyelitis in the mouse. Current Protocols in Immunology 2010, 15.1.1-15.1.20. John Wiley & Sons Inc, NY, (Suppl. 88). Wiley Interscience (Ed.).
40. Mok M.Y., Cheung B.M., Lo Y., Leung R.Y., Wong W.S., Lau C.S. Elevated plasma adrenomedullin and vascular manifestations in patients with systemic sclerosis. J. Rheumatol. 2007, 34:2224-2229.
41. Murugaiyan G., Mittal A., Weiner H.L. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J. Immunol. 2008, 181:7480-7488.
42. Murugaiyan G., Mittal A., Weiner H.L. Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation. Proc. Natl. Acad. Sci. USA 2010, 107:11495-11500.
43. Nagaya N., Satoh T., Nishikimi T., Uematsu M., Furuichi S., Sakamaki F., Oya H., Kyotani S., Nakanishi N., Goto Y., Masuda Y., Miyatake K., Kangawa K. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 2000, 101:498-503.
44. Okura T., Marutsuka K., Hamada H., Sekimoto T., Fukushima T., Asada Y., Kitamura K., Chosa E. Therapeutic efficacy of intra-articular adrenomedullin injection in antigen induced arthritis in rabbits. Arthritis Res. Ther. 2008, 10:R133.
45. Ono Y., Okano I., Kojima M., Okada K., Kangawa K. Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis. Biochem. Biophys. Res. Commun. 2000, 271:197-202.
46. Owens T. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Curr. Opin. Neurol. 2003, 16:259-265.
47. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., Donq C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
48. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., Uccelli A., Lanzavecchia A., Engelhardt B., Sallusto F. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009, 10:514-523.
49. Rullé S., Ah Kioon M.D., Asensio C., Mussard J., Ea H.K., Boissier M.C., Lioté F., Falgarone G. Adrenomedullin, a neuropeptide with immunoregulatory properties induces semi-mature tolerogenic dendritic cells. Immunology 2012, 136:252-264.
50. Shindo T., Kurihara Y., Nishimatsu H., Moriyama N., Kakoki M., Wang Y., Imai Y., Ebihara A., Kuwaki T., Ju K.H., Minamino N., Kangawa K., Ishikawa T., Fukuda M., Akimoto Y., Kawakami H., Imai T., Morita H., Yazaki Y., Nagai R., Hirata Y., Kurihara H. Vascular abnormalities and elevated blood pressure in mice laking adrenomedullin gene. Circulation 2001, 104:1964-1971.
51. Souza-Moreira L., Morell M., Delgado-Maroto V., Pedreño M., Martinez-Escudero L., Caro M., O'Valle F., Luque R., Gallo M., de Lecea L., Castaño J.P., Gonzalez-Rey E. Paradoxical effect of cortistatin treatment and its deficiency on experimental autoimmune encephalomyelitis. J. Immunol. 2013, 191:2144-2154.
52. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996, 85:299-302.
53. Steinman L. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 1999, 24:511-514.
54. Stromnes I.M., Cerretti L.M., Liggitt D., Harris R.A., Goverman J.M. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 2008, 14:337-342.
55. Taskén K., Stokka A.J. The molecular machinery for cAMP-dependent immunomodulation in T-cells. Biochem. Soc. Trans. 2006, 34:476-479.
56. Torgersen K.M., Vang T., Abrahamsen H., Yaqub S., Taskén K. Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell. Signal. 2002, 14:1-9.
57. Vergaño-Vera E., Fernández A.P., Hurtado-Chong A., Vicario-Abejón C., Martínez A. Lack of adrenomedullin affects growth and differentiation of adult neural stem/progenitor cells. Cell Tissue Res. 2010, 340:1-11.
58. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004, 199:971-979.
59. Wong L.Y., Cheung B.M., Li Y.Y., Tang F. Adrenomedullin is both proinflammatory and antiinflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line. Endocrinology 2005, 146:1321-1327.
60. Wu R., Zhou M., Wang P. Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regul. Pept. 2003, 112:19-26.
61. Yang S., Zhou M., Chaudry I.H., Wang P. The role of lipopolysaccharide in stimulating adrenomedullin production during polymicrobial sepsis. Biochem. Biophys. Res. Acta 2001, 1537:167-174.
62. Yudoh K., Matsuno H., Kimura T. Plasma adrenomedullin in rheumatoid arthritis compared with other rheumatic diseases. Arthritis Rheum. 1999, 42:1297-1298.
63. Zudaire E., Portal-Núñez S., Cuttitta F. The central role of adrenomedullin in host defense. J. Leukoc. Biol. 2006, 80:237-244.